Biotech Growth of International According to this column, biotech is a good way to draw more attention to one of the major growth themes of the coming decades: the urge to cure more diseases. We continue to favor these two trusts over BB Biotech, a Swiss alternative.
For investors drawn to biotech but inclined to take less risk, we’ve long been excited for Worldwide Healthcare, which invests in a wider range of companies; it is run by the same management company as Biotech Growth.
Questor says: buy
Tickers: BIOG, IBT, WWH
Share prices at close: 967p, 669p, £33.10
Update: 3i Infrastructure
We’re off to a good start with this confidence, tipping here just a month ago at 314p and already 4.8 pc higher at 329p. We may have been lucky with our timing as this confidence, like so many income-generating assets, got caught up in the chaos that followed the mini-budget, but the fund also released a positive interim report this week.
It reported a total return of 9.3 percent, based on its net asset value, for the six months to the end of September, significantly ahead of its target return of 8 percent to 10 percent per year. The NAV at the end of the period was 325.8p, compared to 303.3p at the end of March.
The interim dividend of 5.575 pence is 6.7 pc. higher than the previous semi-annual payment and the trust said it was on track to pay out 11.15 pence for the full year, also up 6.7 pc. and expected to be fully covered by earnings.
Analysts at Investec, the bank, said: “We believe that 3i Infrastructure gives investors exposure to a high-quality portfolio of economic infrastructure assets and a management team that can demonstrate significant resources to create and operate a portfolio of infrastructure assets. to manage.
“The portfolio continues to perform strongly and given the positive value correlation with both inflation and energy prices, which are expected to remain high, we believe the portfolio remains well positioned to deliver attractive total returns.” Delay.
Questor says: wait
Share price at closing: 329p
News about investment funds
JP Morgan Russian Securities wants to change its investment mandate and name so that it can invest more broadly in “Central, Eastern and Southern Europe (including Russia), the Middle East and Africa”. Currently, his Russian assets are not tradable. A general meeting to approve the proposals will be held on November 23 and shareholders wishing to participate or vote should contact their broker.
JP Morgan Global Growth and Income is absorbing JP Morgan chosen if shareholders approve the merger at a general meeting. The date is not yet known.
Princess Private Equity unexpectedly canceled its dividend due to the cost of settling currency hedging contracts. Shares fell 16.3 percent on the day of the announcement.
Read the last Questor column telegraaf.co.uk every Sunday, Tuesday, Wednesday, Thursday and Friday from 6am.
Read Questor’s rules of investments before following our tips.